DERM
Journey Medical·NASDAQ
--
--(--)
--
--(--)
DERM fundamentals
During Q3 2025, Journey Medical (DERM) reported revenue of 17.63M, a YoY change of 20.52%. Net income was -2.31M, a YoY change of 3.14%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 9.41M -- | 9.45M -- | 13.72M -- | 10.72M -- | 15.29M +62.38% | 19.61M +107.58% | 17.52M +27.65% | 23.30M +117.33% | 18.29M +19.64% | 16.12M -17.82% | 15.97M -8.85% | 12.21M -47.57% | 17.17M -6.12% | 34.54M +114.31% | 15.26M -4.44% | 13.03M +6.69% | 14.86M -13.49% | 14.63M -57.64% | 13.62M -10.73% | 13.14M +0.84% | 15.01M +1.04% | 17.63M +20.52% | 59.40M -- |
Sales and Services Revenue | 9.41M -- | 9.45M -- | 13.72M -- | 10.72M -- | 15.29M +62.38% | 19.61M +107.58% | 17.52M +27.65% | 20.80M +94.01% | 18.23M +19.28% | 16.04M -18.19% | 15.92M -9.11% | 12.16M -41.50% | 16.96M -6.99% | 34.54M +115.29% | -4.26M -126.77% | 13.03M +7.11% | 14.86M -12.42% | 14.63M -57.64% | 12.62M +396.11% | 13.14M +0.84% | 15.01M +1.04% | 17.02M +16.38% | 57.79M -- |
Other Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 2.50M -- | 56.00K -- | 73.00K -- | 45.00K -- | 48.00K -98.08% | 211.00K +276.79% | -- -- | 19.52M +43275.56% | -- -- | -- -- | 0 -- | 1.00M -94.88% | -- -- | -- -- | 606.00K -- | -- -- |
Cost of Revenue | 3.12M -- | 3.38M -- | 4.28M -- | 3.91M -- | 7.48M +139.56% | 11.17M +230.48% | 9.53M +122.49% | 8.20M +109.90% | 7.63M +1.99% | 7.22M -35.34% | 7.72M -18.97% | 6.45M -21.38% | 7.77M +1.76% | 6.43M -10.97% | 2.25M -70.87% | 6.82M +5.69% | 6.54M -15.78% | 4.47M -30.46% | 2.24M -0.49% | 5.86M -14.10% | 6.00M -8.23% | 5.75M +28.72% | 19.85M -- |
Cost of Goods and Services | -- -- | -- -- | 14.59M -- | -- -- | -- -- | -- -- | 32.08M +119.84% | -- -- | -- -- | -- -- | 30.77M -4.08% | -- -- | -- -- | 6.43M -- | 2.25M -92.70% | 6.00M -- | 5.73M -- | 4.47M -30.46% | 4.68M +108.19% | 4.79M -20.19% | 4.94M -13.76% | 5.75M +28.72% | 20.16M -- |
Gross Profit | 6.29M -- | 6.07M -- | 9.44M -- | 6.81M -- | 7.80M +24.05% | 8.44M +39.14% | 7.99M -15.36% | 15.09M +121.60% | 10.66M +36.57% | 8.89M +5.35% | 8.25M +3.20% | 5.76M -61.81% | 9.40M -11.76% | 28.11M +216.02% | 13.01M +57.72% | 7.03M +21.93% | 9.13M -2.95% | 10.16M -63.86% | 8.94M -31.28% | 8.35M +18.80% | 10.07M +10.32% | 11.88M +16.91% | 39.23M -- |
Other Operating Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 4.55M -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 4.75M -- | 5.83M -- | 5.82M -- | 6.23M -- | 21.57M +353.85% | 21.09M +261.79% | 17.05M +193.14% | 15.98M +156.68% | 17.80M -17.47% | 18.39M -12.81% | 18.24M +7.00% | 15.32M -4.10% | 17.06M -4.17% | 10.87M -40.91% | 15.11M -17.16% | 17.12M +11.70% | 12.05M -29.33% | 13.05M +20.13% | 11.26M -25.50% | 11.67M -31.81% | 12.95M +7.39% | 13.40M +2.70% | 49.28M -- |
Selling, General and Administrative Expenses | 4.75M -- | 5.83M -- | 5.82M -- | 6.23M -- | 7.79M +64.04% | 10.76M +84.51% | 15.06M +158.89% | 14.71M +136.35% | 15.19M +94.88% | 15.57M +44.82% | 13.99M -7.11% | 13.29M -9.67% | 12.14M -20.08% | 8.64M -44.55% | 13.61M -2.71% | 9.23M -30.53% | 11.14M -8.23% | 12.21M +41.38% | 11.04M -18.86% | 11.63M +25.99% | 12.95M +16.19% | 13.12M +7.44% | 48.74M -- |
Research and Development Expenses | -- -- | -- -- | 0 -- | -- -- | 13.77M -- | 794.00K -- | 1.99M -- | 1.27M -- | 2.61M -81.06% | 2.81M +254.16% | 4.26M +113.65% | 2.03M +60.58% | 1.77M -32.00% | 2.23M -20.73% | 1.50M -64.64% | 7.88M +287.80% | 913.00K -48.53% | 842.00K -62.23% | 218.00K -85.51% | 39.00K -99.51% | 0 -100.00% | 287.00K -65.91% | 544.00K -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -- -- | -- -- | 0 -- | -- -- | -- -- | 9.54M -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | 3.14M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | 1.54M -- | 239.00K -- | 3.63M -- | 585.00K -- | -13.76M -994.28% | -12.65M -5391.21% | -9.06M -349.78% | -888.00K -251.79% | -7.14M +48.11% | -9.49M +24.94% | -9.99M -10.36% | -9.56M -976.69% | -7.65M -7.15% | 17.25M +281.68% | -2.10M +78.95% | -10.09M -5.53% | -2.93M +61.75% | -2.89M -116.78% | 2.23M +206.18% | -3.32M +67.06% | -2.88M +1.74% | -1.53M +47.17% | -5.50M -- |
Non-Operating Income (Loss) | -155.00K -- | -187.00K -- | -206.00K -- | -221.00K -- | -1.52M -883.23% | -1.38M -635.29% | -4.36M -2016.02% | -386.00K -74.66% | -450.00K +70.47% | -578.00K +57.96% | -634.00K +85.46% | -575.00K -48.96% | -710.00K -57.78% | -361.00K +37.54% | 87.00K +113.72% | -352.00K +38.78% | -434.00K +38.87% | 504.00K +239.61% | -652.00K -849.43% | -749.00K -112.78% | -860.00K -98.16% | -786.00K -255.95% | -3.05M -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -447.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -89.00K -- | -- -- | -- -- | -101.00K -- | -2.00K +97.75% | -21.00K -- | -32.00K -- | -51.00K +49.50% | -12.00K -500.00% | -7.00K +66.67% | -61.00K -90.63% | -3.00K +94.12% | -83.00K -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -182.00K -- | -2.00K -- | 184.00K -- | -- -- | -- -- | -22.00K -1000.00% | 22.00K -88.04% | -47.00K -- | -33.00K -- | 0 +100.00% | 0 -100.00% | -- -- | -- -- | 1.13M -- | 0 -- | -- -- | -- -- | 0 -100.00% | -- -- |
Net Interest Expense | 155.00K -- | 187.00K -- | 206.00K -- | 221.00K -- | 1.34M +765.81% | 1.37M +634.22% | 4.10M +1888.35% | 386.00K +74.66% | 450.00K -66.47% | 556.00K -59.50% | 567.00K -86.16% | 528.00K +36.79% | 677.00K +50.44% | 260.00K -53.24% | -89.00K -115.70% | 331.00K -37.31% | 402.00K -40.62% | 570.00K +119.23% | 640.00K +819.10% | 742.00K +124.17% | 799.00K +98.76% | 783.00K +37.37% | 2.96M -- |
Interest Expense | 155.00K -- | 187.00K -- | 206.00K -- | 221.00K -- | 1.34M +765.81% | 1.37M +634.22% | 4.10M +1889.32% | 389.00K +76.02% | 454.00K -66.17% | 559.00K -59.29% | 617.00K -84.94% | 650.00K +67.10% | 756.00K +66.52% | 268.00K -52.06% | 24.00K -96.11% | 548.00K -15.69% | 563.00K -25.53% | 758.00K +182.84% | 831.00K +3362.50% | 891.00K +62.59% | 937.00K +66.43% | 937.00K +23.61% | 3.60M -- |
Interest Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 2.00K -- | 3.00K -- | 4.00K -- | 3.00K -- | 50.00K +2400.00% | 122.00K +3966.67% | 79.00K +1875.00% | 8.00K +166.67% | 113.00K +126.00% | 217.00K +77.87% | 161.00K +103.80% | 188.00K +2250.00% | 191.00K +69.03% | 149.00K -31.34% | 138.00K -14.29% | 154.00K -18.09% | 632.00K -- |
Pretax Income From Continuing Operations | 1.38M -- | 52.00K -- | 3.42M -- | 364.00K -- | -15.29M -1204.55% | -14.02M -27063.46% | -13.42M -492.28% | -1.27M -450.00% | -7.59M +50.34% | -10.07M +28.18% | -10.63M +20.77% | -10.14M -695.60% | -8.36M -10.16% | 16.88M +267.67% | -2.02M +81.02% | -10.44M -3.02% | -3.36M +59.81% | -2.39M -114.16% | 1.58M +178.43% | -4.07M +60.99% | -3.74M -11.16% | -2.31M +3.14% | -8.54M -- |
Income Tax Expense | 929.00K -- | 23.00K -- | 918.00K -- | 96.00K -- | -3.42M -468.35% | -3.38M -14773.91% | 8.34M +807.95% | 104.00K +8.33% | -64.00K +98.13% | 10.00K +100.30% | 13.00K -99.84% | -- -- | -- -- | 95.00K +850.00% | 126.00K +869.23% | -- -- | -- -- | 0 -100.00% | 61.00K -51.59% | -- -- | 60.00K -- | 0 -- | -- -- |
Current Income Tax | -- -- | -- -- | 2.21M -- | -- -- | -- -- | -- -- | 67.00K -96.96% | -- -- | -- -- | -- -- | 63.00K -5.97% | -- -- | -- -- | -- -- | 221.00K +250.79% | -- -- | -- -- | -- -- | 60.00K -72.85% | -- -- | -- -- | -- -- | -- -- |
Deferred Income Tax | -- -- | -- -- | -335.00K -- | -- -- | -- -- | -- -- | -9.30M -2677.01% | -- -- | -- -- | -- -- | -8.44M +9.30% | -- -- | -- -- | -- -- | -847.00K +89.96% | -- -- | -- -- | -- -- | -3.89M -359.03% | -- -- | -- -- | -- -- | -- -- |
Income Tax Adjustments | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 10.87M -- | -- -- | -- -- | -- -- | 8.44M -22.37% | -- -- | -- -- | -- -- | 847.00K -89.96% | -- -- | -- -- | -- -- | 3.89M +359.15% | -- -- | -- -- | -- -- | -- -- |
Net Income | 455.00K -- | 29.00K -- | 2.50M -- | 268.00K -- | -11.87M -2707.69% | -10.65M -36810.34% | -21.75M -969.34% | -1.38M -614.18% | -7.53M +36.55% | -10.08M +5.32% | -10.64M +51.07% | -10.14M -635.56% | -8.36M -11.09% | 16.79M +266.56% | -2.14M +79.86% | -10.44M -3.02% | -3.36M +59.81% | -2.39M -114.24% | 1.52M +170.98% | -4.07M +60.99% | -3.80M -12.94% | -2.31M +3.14% | -8.66M -- |
Net Income Attributable to Owners of the Company | 455.00K -- | 29.00K -- | 2.50M -- | 268.00K -- | -11.87M -2707.69% | -10.65M -36810.34% | -21.75M -969.34% | -1.38M -614.18% | -7.53M +36.55% | -10.08M +5.32% | -10.64M +51.07% | -10.14M -635.56% | -8.36M -11.09% | 16.79M +266.56% | -2.14M +79.86% | -10.44M -3.02% | -3.36M +59.81% | -2.39M -114.24% | 1.52M +170.98% | -4.07M +60.99% | -3.80M -12.94% | -2.31M +3.14% | -8.66M -- |
Net Income Attributable to Common Stockholders | 455.00K -- | 29.00K -- | 2.50M -- | 268.00K -- | -11.87M -2707.69% | -10.65M -36810.34% | -21.75M -969.34% | -1.38M -614.18% | -7.53M +36.55% | -10.08M +5.32% | -10.64M +51.07% | -10.14M -635.56% | -8.36M -11.09% | 16.79M +266.56% | -2.14M +79.86% | -10.44M -3.02% | -3.36M +59.81% | -2.39M -114.24% | 1.52M +170.98% | -4.07M +60.99% | -3.80M -12.94% | -2.31M +3.14% | -8.66M -- |
Other Comprehensive Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | 5.28M -- | -- -- | -- -- | -- -- | -43.99M -932.75% | -- -- | -- -- | -- -- | -29.63M +32.65% | -- -- | -- -- | 16.79M -- | -2.14M +92.77% | -10.44M -- | -3.36M -- | -- -- | -14.67M -584.65% | -4.07M +60.99% | -3.80M -12.94% | -- -- | -- -- |
Basic EPS | 0.05 -- | 0 -- | -- -- | 0.03 -- | -1.3 -2700.00% | -1.16 -- | -1.26 -- | -0.08 -366.67% | -0.43 +66.92% | -0.57 +50.86% | -0.6 +52.38% | -0.57 -612.50% | -0.46 -6.98% | 0.91 +259.65% | -0.11 +81.67% | -0.53 +7.02% | -0.17 +63.04% | -0.12 -113.19% | 0.07 +163.64% | -0.18 +66.04% | -0.16 +5.88% | -0.09 +25.00% | -0.36 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.91 -- | -- -- | -0.53 -- | -0.17 -- | -0.12 -113.19% | -- -- | -0.18 +66.04% | -0.16 +5.88% | -0.09 +25.00% | -- -- |
Diluted EPS | 0.04 -- | 0 -- | -- -- | 0.02 -- | -1.3 -3350.00% | -1.16 -- | -- -- | -0.08 -500.00% | -0.43 +66.92% | -0.57 +50.86% | -- -- | -0.57 -612.50% | -0.46 -6.98% | 0.8 +240.35% | -- -- | -0.53 +7.02% | -0.17 +63.04% | -0.12 -115.00% | -- -- | -0.18 +66.04% | -0.16 +5.88% | -0.09 +25.00% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.8 -- | -- -- | -0.53 -- | -0.17 -- | -0.12 -115.00% | -- -- | -0.18 +66.04% | -0.16 +5.88% | -0.09 +25.00% | -- -- |
You can ask Aime
What factors drove the changes in Journey Medical's revenue and profit?What were the key takeaways from Journey Medical’s earnings call?What were the key takeaways from Journey Medical's earnings call?What is the market's earnings forecast for Journey Medical next quarter?Did Journey Medical beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Journey Medical year over year?What is Journey Medical's gross profit margin?What guidance did Journey Medical's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
